Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses

Vaccine

Volumn 23, Issue 32, 2005, Pages 4101-4109

  Brookes, S M ^a   Parsons, G ^a   Johnson, N ^a   McElhinney, L M ^a   Fooks, A R ^a  

^a VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

Cross protection; Lyssaviruses; Rabies; Vaccine

Indexed keywords

DIPLOID CELL VACCINE; RABIES HUMAN DIPLOID CELL VACCINE; RABIES VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAT; CONTROLLED STUDY; DATA ANALYSIS; DRUG EFFECT; DRUG SCREENING; FLUORESCENT ANTIBODY TECHNIQUE; HUMORAL IMMUNITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROVOCATION TEST; RABIES; RABIES VIRUS; STATISTICAL SIGNIFICANCE; VIRUS NEUTRALIZATION; VIRUS STRAIN;

ANIMALS; ANTIBODIES, VIRAL; CELL CULTURE TECHNIQUES; CHIROPTERA; CROSS REACTIONS; EUROPE; HUMANS; IMMUNIZATION; LASSA FEVER; LASSA VIRUS; MICE; RABIES; RABIES VACCINES; RABIES VIRUS;

EID: 20444450119     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.03.037     Document Type: Article

References (52)

1. H. Bourhy, B. Kissi, M. Lafon, D. Sacramento, and N. Tordo Antigenic and molecular characterization of bat rabies virus in Europe J Clin Microbiol 30 9 1992 2419 2426
2. O.P. Larghi, and A.M. Diaz Cross protection of mice against different rabies virus isolates Zentralbl Bakteriol Mikrobiol Hyg [A] 259 2 1985 268 274
3. H. Koprowski, T.J. Wiktor, and M.K. Abelseth Cross-reactivity and cross-protection: rabies variants and rabies-related viruses E. Kuwert C. Merieux H. Koprowski K. Bogel Rabies in the tropic 1985 Springer-Verlag Berlin 30 39
4. H. Badrane, C. Bahloul, P. Perrin, and N. Tordo Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity J Virol 75 7 2001 3268 3276
5. A.D. Botvinkin, I.V. Kuzmin, and S.N. Rybin The unusual bat Lyssavirus Aravan from Central Asia Myotis 34 1996 101 104
6. A.D. Botvinkin, E.M. Poleschuk, I.V. Kuzmin, T.I. Borisova, S.V. Gazaryan, and P. Yager Novel Lyssaviruses isolated from bats in Russia Emerg Infect Dis 9 12 2003 1623 1625
7. Y.T. Arai, I.V. Kuzmin, Y. Kameoka, and A.D. Botvinkin New Lyssavirus genotype from the lesser mouse-eared bat (Myotis blythi), Kyrghyzstan Emerg Infect Dis 9 3 2003 1 9
8. WHO 9th report. The expert consultation on rabies with the participation of the network of WHO Collaborating Centers on Rabies was held in Geneva 5-8 October 2004, http://www.who.int/rabies/resources/en/.
9. Anon. MMWR 1999;48(RR-1):1-21.
10. O. Thraenhart, I. Marcus, and E. Kreuzfelder Current and future immunoprophylaxis against human rabies: reduction of treatment failures and errors Curr Top Microbiol Immunol 187 1994 173 194
11. M.J. Warrell, and D.A. Warrell Rabies and other lyssavirus diseases Lancet 363 9413 2004 959 969
12. L.G. Schneider Antigenic variants of rabies virus Comp Immunol Microbiol Infect Dis 5 1-3 1982 101 117
13. E.B. Seligmann Jr. Laboratory techniques in rabies: the NIH test for potency Monogr Ser World Health Organ 23 1973 279 286
14. A. Flamand, P. Coulon, F. Lafay, and C. Tuffereau Avirulent mutants of rabies virus and their use as live vaccine Trends Microbiol 1 8 1993 317 320
15. J. Blancou, M.F. Aubert, E. Cain, M. Selve, O. Thraenhart, and L. Bruckner Effect of strain differences on the potency testing of rabies vaccines in mice J Biol Stand 17 3 1989 259 266
16. D.L. Lodmell, J.S. Smith, J.J. Esposito, and L.C. Ewalt Cross-protection of mice against a global spectrum of rabies virus variants J Virol 69 8 1995 4957 4962
17. P.S. Wunderli, D.W. Dreesen, T.J. Miller, and G.M. Baer Effects of vaccine route and dosage on protection from rabies after intracerebral challenge in mice Am J Vet Res 64 4 2003 491 498
18. P.S. Wunderli, D.W. Dreesen, T.J. Miller, and G.M. Baer Effect of heterogeneity of rabies virus strain and challenge route on efficacy of inactivated rabies vaccines in mice Am J Vet Res 64 4 2003 499 505
19. I. Vodopija, P. Sureau, S. Smerdel, M. Lafon, Z. Baklaic, and M. Ljubicic Comparative study of two human diploid rabies vaccines administered with antirabies globulin Vaccine 6 6 1988 489 490
20. M. Herzog, C. Fritzell, M. Lafage, J.A. Montano Hirose, D. Scott-Algara, and M. Lafon T and B cell human responses to European bat Lyssavirus after post-exposure rabies vaccination Clin Exp Immunol 85 2 1991 224 230
21. P. Coulon, F. Lafay, and A. Flamand Rabies virus antigenicity: an overview Onderstepoort J Vet Res 60 4 1993 271 275
22. M. Aubert Can vaccination validated by the titration of rabies antibodies in serum of cats and dogs be an alternative to quarantine measures Abstr Hyg Commun Dis 68 1993 R1 R22
23. A.A. King Cell culture of rabies virus F.X. Meslin M.M. Kaplan H. Koprowski Laboratory techniques in rabies 4th ed. 1996 WHO Geneva 114 130
24. H. Koprowski The mouse inoculation test F.X. Meslin M.M. Kaplan H. Koprowski Laboratory techniques in rabies 4th ed. 1996 WHO Geneva 80 87
25. F. Cliquet, M. Aubert, and L. Sagne Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody J Immunol Methods 212 1 1998 79 87
26. Office International des Epizooties. Rabies. In: Manual of standards - diagnostic tests and vaccines. 4th ed. 2000, http://www.oie.int/eng/normes/ mmanual/A_00042.htm.
27. L.A. Wilbur, and M.F.A. Aubert The NIH test for potency F.X. Meslin M.M. Kaplan H. Koprowski Laboratory techniques in rabies 4th ed. 1996 WHO Geneva
28. J. Hartinger, T. Folz, and K. Cussler Clinical endpoints during rabies vaccine control tests ALTEX 18 1 2001 37 40
29. D.J. Dean, M.K. Abelseth, and P. Atanasiu The fluorescent antibody test F.X. Meslin M.M. Kaplan H. Koprowski Laboratory techniques in rabies 4th ed. 1996 WHO Geneva 88 95
30. P.R. Heaton, P. Johnstone, L.M. McElhinney, R. Cowley, E. O'Sullivan, and J.E. Whitby Heminested PCR assay for detection of six genotypes of rabies and rabies-related viruses J Clin Microbiol 35 11 1997 2762 2766
31. N. Johnson, L.M. McElhinney, J. Smith, P. Lowings, and A.R. Fooks Phylogenetic comparison of the genus Lyssavirus using distal coding sequences of the glycoprotein and nucleoprotein genes Arch Virol 147 11 2002 2111 2123
32. P. Perrin, L. Thibodeau, and P. Sureau Rabies immunosome (subunit vaccine) structure and immunogenicity. Pre- and post-exposure protection studies Vaccine 3 3 1985 325 332
33. T.J. Wiktor, E. Gyorgy, D. Schlumberger, F. Sokol, and H. Koprowski Antigenic properties of rabies virus components J Immunol 110 1 1973 269 276
34. T.J. Wiktor, P.C. Doherty, and H. Koprowski In vitro evidence of cell-mediated immunity after exposure of mice to both live and inactivated rabies virus Proc Natl Acad Sci USA 74 1 1977 334 338
35. P. Perrin, M. Tino de Franco, C. Jallet, F. Fouque, S. Morgeaux, and N. Tordo The antigen-specific cell-mediated immune response in mice is suppressed by infection with pathogenic lyssaviruses Res Virol 147 5 1996 289 299
36. H. Bunschoten, R.J. Klapmuts, I.J. Claassen, S.D. Reyneveld, A.D. Osterhaus, and F.G. Uytdehaag Rabies virus-specific human T cell clones provide help for an in vitro antibody response against neutralizing antibody-inducing determinants of the viral glycoprotein J Gen Virol 70 1989 1513 1521
37. L.G. Schneider Antigenic variants of rabies virus Comp Immunol Microbiol Infect Dis 5 1-3 1982 101 117
38. B. Dietzschold, M. Tollis, C.E. Rupprecht, E. Celis, and H. Koprowski Antigenic variation in rabies and rabies-related viruses: cross-protection independent of glycoprotein-mediated virus-neutralizing antibody J Infect Dis 156 5 1987 815 822
39. M. Fekadu, J.H. Shaddock, D.W. Sanderlin, and J.S. Smith Efficacy of rabies vaccines against Duvenhage virus isolated from European house bats (Eptesicus serotinus), classic rabies and rabies-related viruses Vaccine 6 6 1988 533 539
40. M. Lafon, H. Bourhy, and P. Sureau Immunity against the European bat rabies (Duvenhage) virus induced by rabies vaccines: an experimental study in mice Vaccine 6 4 1988 362 368
41. C. Jallet, Y. Jacob, C. Bahloul, A. Drings, E. Desmezieres, and N. Tordo Chimeric Lyssavirus glycoproteins with increased immunological potential J Virol 73 1 1999 225 233
42. M. Fekadu Bat rabies: pathogenesis and vaccine efficacy AM. Greenhall M. Artois M. Fekadu Bats and rabies 1993 Foundation Marcel Merieux Lyon 75 106
43. Hanlon CA, Kuzmin I, Blanton J, Manangan J, Murphy SM, Rupprecht CE. Efficacy of biologics against newly described lyssaviruses. In: Proceedings of 14th International conference on Rabies in the Americas, October 2003, p. 55-56.
44. Brookes SM, Aegerter JN, Smith GC, Healy DM, Jolliffe TA, Swift SM, et al. European bat lyssavirus in Scottish bats. Emerg Infect Dis [serial on the Internet]. 2005 April [date cited], http://www.cdc.gov/ncidod/EID/vol11no04/04- 0920.htm.
45. C.A. Hanlon, C.A. DeMattos, C.C. DeMattos, M. Niezgoda, D.C. Hooper, and H. Koprowski Experimental utility of rabies virus-neutralizing human monoclonal antibodies in post-exposure prophylaxis Vaccine 19 28-29 2001 3834 3842
46. W.H. Wunner, B. Dietzschold, P.J. Curtis, and T.J. Wiktor Rabies subunit vaccines J Gen Virol 64 Pt 8 1983 1649 1656
47. P.S. Wunderli, J.H. Shaddock, D.S. Schmid, T.J. Miller, and G.M. Baer The protective role of humoral neutralizing antibody in the NIH potency test for rabies vaccines Vaccine 9 9 1991 638 642
48. G.M. Baer, W.F. Cleary, A.M. Diaz, and D.F. Perl Characteristics of 11 rabies virus isolates in mice: titers and relative invasiveness of virus, incubation period of infection, and survival of mice with sequelae J Infect Dis 136 3 1977 336 345
49. B. Dietzschold, W.H. Wunner, T.J. Wiktor, A.D. Lopes, M. Lafon, and C.L. Smith Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus Proc Natl Acad Sci USA 80 1 1983 70 74
50. I. Seif, P. Coulon, P.E. Rollin, and A. Flamand Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein J Virol 53 3 1985 926 934
51. N. Tordo, H. Badrane, H. Bourhy, and D. Sacramento Molecular epidemiology of lyssaviruses: focus on the glycoprotein and pseudogenes Onderstepoort J Vet Res 60 4 1993 315 323
52. H. Bourhy, B. Kissi, and N. Tordo Molecular diversity of the Lyssavirus genus Virology 194 1 1993 70 81